Citius Pharmaceuticals, Inc.
CTXR
$0.58
-$0.02-3.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 179.31% | 17,287.12% | 601.88% | 30.76% | -66.00% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | 31.48% | 47.72% | 57.42% | 169.53% | -- |
| Prepaid Expenses | 129.34% | 11.57% | 24.23% | -48.31% | -86.99% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 76.06% | 72.44% | 107.04% | 96.44% | -12.12% |
|
|
|||||
| Total Current Assets | 76.06% | 72.44% | 107.04% | 96.44% | -12.12% |
| Net Property, Plant & Equipment | -14.50% | -13.84% | 336.36% | 232.53% | 193.66% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -4.33% | -2.47% | -0.62% | 0.00% | 56.23% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 444.09% | 0.00% | 0.00% | 0.00% |
| Total Assets | 11.42% | 9.10% | 16.31% | 12.25% | 31.50% |
|
|
|||||
| Total Accounts Payable | -20.37% | 0.91% | 49.66% | 177.92% | 506.87% |
| Total Accrued Expenses | 127.12% | 131.88% | -11.88% | 233.16% | 442.95% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 53.62% | 18.19% | -27.66% | -63.44% | -51.32% |
| Total Finance Division Other Current Liabilities | -44.89% | -37.85% | -35.74% | -20.25% | -- |
| Total Other Current Liabilities | -44.89% | -37.85% | -35.74% | -20.25% | -- |
| Total Current Liabilities | -0.37% | 10.30% | -14.73% | 25.41% | 1,148.59% |
|
|
|||||
| Total Current Liabilities | -0.37% | 10.30% | -14.73% | 25.41% | 1,148.59% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -22.97% | -19.07% | -- | 3,303.29% | 808.77% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.53% | 7.75% | 15.15% | 15.74% | 14.26% |
| Total Liabilities | 10.36% | 9.59% | -9.39% | 25.52% | 456.30% |
|
|
|||||
| Common Stock & APIC | 16.16% | 16.65% | 18.24% | 12.86% | 7.11% |
| Retained Earnings | -20.05% | -20.81% | -17.00% | -18.59% | -21.13% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 2.39% | 1.45% | 22.25% | -3.61% | -24.07% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.39% | 1.45% | 22.25% | -3.61% | -24.07% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 271.46% | 158.64% | 284.74% | 147.92% | 316.79% |
| Total Equity | 12.36% | 8.66% | 35.62% | 4.62% | -21.70% |
|
|
|||||